Advocacy in Action
The Endocrine Society examines the recent release of the LHHS Appropriations Subcommittee bill as well as the CMS proposed physician fee schedule rule for FY24.
Related Articles
Staging schema for early diagnosis of prediabetes
In this Comment, we propose a staging schema for the early diagnosis of prediabetes (intermediate hyperglycaemia) and type 2 diabetes by use of 1-h plasma…
Closed-loop systems: a bridge to cell therapy for type 1 diabetes?
Despite considerable advances in treatments and technologies for people with type 1 diabetes, the treatment framework has remained largely unchanged since insulin was discovered 100…
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Bonnie R. Giller, MS, RDN, CDN, CDCES, registered dietitian nutritionist and certified intuitive eating counselor, about…
American Diabetes Month
November is American Diabetes Month®, but this isn’t a time to celebrate. It’s a time to rally against the diabetes epidemic. The ADA is leading…
Continuous glucose sensor accuracy: beyond the headline metric
The promotion of continuous glucose monitoring (CGM) to standard of care for type 1 diabetes and insulin-treated type 2 diabetes reflects a robust and wide…
Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations
People with diabetes often encounter stigma (ie, negative social judgments, stereotypes, prejudice), which can adversely affect emotional, mental, and physical health; self-care, access to optimal…
All the Rage: Combatting Counterfeit Weight-Loss and Diabetes Drugs – Endocrine News
As online ads abound for diabetes and obesity medications, endocrinologists should be prepared to talk to patients who may be attracted to GLP-1 drug lookalikes…
An integrated diabetes and mental health intervention for people with type 1 diabetes and severe disordered eating: a prospective proof-of-concept cohort study
Disordered eating is a phenomenon that affects approximately 30% of people with type 1 diabetes, and is characterised by omission of some amount of insulin…
ESE Spotlight on Science: Metabolic dysfunction associated steatotic liver disease (MASLD) | ESE
Please note: ESE does not permit attendance of sanctioned individuals or individuals from sanctioned institutions at any ESE events. Please click here to see ESE’s…
A roadmap for integrating mental health and diabetes services
It is well recognised that people with long-term conditions, including diabetes, have higher rates of mental disorders and disease-specific psychological burden. There is an increasing…